Full profile >
James HoulderPartner & Director of Research
Full profile >
Life Sciences & Health Technology Practice
Medical Devices, Medical Diagnostics, Medical Technology, Drug Discovery & Drug Development
Bailey Fisher’s Life Sciences & Health Technology team works in partnership with innovative companies to build impactful boards and senior executive teams contributing to sustainable company growth and success.
Headquartered in the globally renowned biotech cluster of Cambridge, we work with companies at the cutting edge of the market, from emerging growth ventures and their investors to established corporates looking to innovate.
We have a wealth of knowledge and an unrivalled network of entrepreneurs, industry experts, investors and advisors, built up over 20 years working with growth companies. We take the time to fully understand the needs of our clients’ businesses, taking into account both current and future requirements as the company grows. We ensure that all individuals we introduce to our clients share the ambitions for success, with a drive to impact the growth of the company.
We can assist you with hiring the following: Chairman/Non-Executive Director, CEO/MD/COO, Commercial Leadership & Technical Leadership roles.
The Life Sciences & Health Technology Practice is led by Iain Hopper and James Houlder. Iain has a background in international search, including 6 years in Sydney, where he focused on pharmaceuticals and biotechnology, working with market leaders including Roche, Novartis and Gilead on senior and executive level appointments in the Australian, New Zealand and SE Asian markets.
James has extensive search experience, as Director at Bailey Fisher for the past 4 years, handling a broad range of technical and commercial roles, from Chair/NED to Head of R&D; and previously as an in-house recruiter for large corporates including MedImmune and Illumina.
Iain and James host a series of events offering a forum for senior executives in Life Sciences and Health Technology to meet with their peers to discuss highly relevant commercial issues. Recently we have welcome guest speakers including Shaun Grady – VP at AstraZeneca; Vishal Gulati – Partner at Draper Esprit; Denise Scots-Knight – CEO of Mereo Biopharma; Fiona Marshall – Founder/CSO of Heptares (acquired by Sosei Group) and David Brown, a renowned serial entrepreneur, advisor and board member, who is named as co-inventor on the patent for Viagra.